2015 Nicholson Lecture "Hepatitis C: 26 Years Later" with Professor Charles M. Rice
Dr. Charles M. Rice, Maurice R. and Corinne P. Greenberg Professor in Virology, Rockefeller University, New York, USA. Globally, an estimated 130 million people are infected with hepatitis C virus (HCV), a major cause of acute hepatitis and chronic liver disease, including cirrhosis and liver cancer. There is currently no HCV vaccine, and although new antiviral drugs were recently approved and are clinically available, more will be needed to combat resistance and target all genotypes. Dr. Rice’s lab focuses on understanding virus replication, host responses to infection and developing new therapies to treat HCV and other viral pathogens.
Refreshments will be served after the lecture. Please register here so we know how many to cater for! (deadline extended)
For more information, please see our press invitation.
Open and free for all - welcome!
Welcome by Professor Anders Hamsten, Vice-Chancellor, Karolinska Institutet
Hepatitis C in Global Health Priorities by Hans Rosling, Professor, Karolinska Institutet
Introduction of Nicholson Lecturer 2015 by Hans-Gustaf Ljunggren, Dean of Research, Karolinska Institutet
Hepatitis C: 26 Years Later by Charles M. Rice, Nicholson Lecturer 2015, Rockefeller University
Questions from the Audience
Closing Remarks by Anders Hamsten, Vice-Chancellor, Karolinska Institutet
Refreshments will be served outside the auditorium after the lecture.Contact person: Johanna Diehl